TRxADE HEALTH Inc.

NASDAQ: MEDS · Real-Time Price · USD
7.59
0.33 (4.55%)
At close: Sep 20, 2024, 10:00 PM

TRxADE HEALTH Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 10.26K 53.08K 64.86K 18.7K n/a 2.35M 2.06M 2.25M 2.25M 2.53M 2.4M 3.28M 3.24M 2.39M 2.55M 1.9M 3.05M
Cost of Revenue
n/a 9.59K 41.95K 60.98K 19.4K 8.3K 4.6M 353.45K 606.35K 690.67K 986.35K 998.32K 2.11M 1.9M 1.15M 1.27M 1.06M 1.67M
Gross Profit
n/a 673.00 11.13K 3.88K -703 -8.3K -2.25M 1.7M 1.64M 1.56M 1.54M 1.4M 1.17M 1.34M 1.24M 1.28M 841.39K 1.38M
Operating Income
-6.72M -3.06M -8.29M -3.5M -1.5M -5.5M -6.19M -845.15K -345.63K -347.41K -277.84K -407.03K -1.1M -968.57K -782.32K -1.3M -2.57M -644.25K
Interest Income
63.15K 25.44K 1.94K 29.45K 41.03K 62.92K n/a n/a n/a 4.2K 12.59K 8.4K n/a n/a n/a n/a n/a n/a
Pretax Income
-6.72M -3.06M 21.05M -3.18M -1.62M -6.64M -11.72M -171.61K -1.97M -325.71K -1.3M -528.74K -1.11M -965.84K -784.34K -1.3M -2.58M -651.52K
Net Income
-6.72M -3.06M -7.34M -3.18M -1.83M -8.44M -11.72M -3.53M -1.97M -62.39K -1.77M -503K -1.08M -956.05K -784.34K -1.3M -2.58M -651.52K
Selling & General & Admin
3.14M 1.77M -850.79K 2.09M 1.41M 5.49M 3.58M 2.14M 1.55M 1.67M 1.5M 1.51M 1.98M 2.06M 2.02M 2.58M 2.19M 2.03M
Research & Development
843.55K 574.68K 928.85K 1.25M n/a 53.86K 366.53K 410.61K 441.38K 233.29K 318.42K 298.59K 298.06K 245.78K 1.37M n/a n/a n/a
Other Expenses
1.18M 1.22M 4.01M 157.47K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.62M -1.28K n/a n/a
Operating Expenses
5.16M 3.56M 4.09M 3.5M 1.49M 5.49M 3.94M 2.55M 1.99M 1.9M 1.82M 1.81M 2.27M 2.3M 2.02M 2.58M 2.19M 2.03M
Interest Expense
-653.49K -670.78K -1.66M 217.43K 4.95K 98.52K 703.44K 251.78K 180.73K 62.39K 195.58K 130.11K 9.15K 1.36K 2.02K 5.62K 8.69K 7.26K
Selling & Marketing Expenses
n/a n/a -607.77K n/a n/a 607.77K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 3.57M 4.13M 3.56M 1.51M 5.5M 8.55M 2.9M 2.6M 2.6M 2.81M 2.81M 4.38M 4.21M 3.17M 3.84M 3.24M 3.7M
Income Tax Expense
n/a n/a -1.27M n/a n/a 1.8M n/a 3.61M 180.73K -263.32K 464.36K -25.74K n/a n/a 2.02K 5.62K 8.69K n/a
Shares Outstanding (Basic)
14.14M 4.71M 3.38M 2.37M 1.41M 1.04M 931.88K 771.19K 681.2K 670.72K 618.81K 549.98K 545.4K 545.21K 544.46K 544.24K 541.48K 539.55K
Shares Outstanding (Diluted)
14.14M 4.71M 3.65M 2.37M 1.41M 1.04M 931.88K 771.19K 681.2K 670.72K 618.81K 549.98K 545.4K 545.21K 544.46K 544.24K 541.48K 539.55K
EPS (Basic)
-0.48 -0.65 13.47 -1.34 -1.3 -8.14 -12.57 -4.57 -2.9 -0.09 -2.86 -0.91 -1.99 -1.75 -1.44 -2.39 -4.76 -1.21
EPS (Diluted)
-0.48 -0.65 13.26 -1.34 -1.3 -8.14 -12.57 -4.57 -2.9 -0.09 -2.86 -0.91 -1.99 -1.75 -1.44 -2.39 -4.76 -1.21
EBITDA
-6.72M -3.06M 19.58M -2.94M -1.62M -5.49M -5.48M -171.61K -1.97M -290.89K -1.06M -342.47K -1.07M -910.27K -746.1K -1.26M -2.54M -610.83K
EBIT
n/a n/a 11.12M -2.97M -1.62M -6.54M -11.01M 163.64K -2.05M -1.07M -1.11M -210.37K -1.1M -964.47K -782.32K -1.3M -2.57M -644.25K
Depreciation & Amortization
n/a n/a -16.67K 22.64K 8.36K 8.3K 715.45K 328.74K 53.52K 52.32K 65.89K 64.56K 36.51K 58.3K 36.22K 35.04K 34.22K 33.43K